These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A new combined trivalent live measles (AIK-C strain), mumps (Hoshino strain), and rubella (Takahashi strain) vaccine. Findings in clinical and laboratory studies. Makino S, Sasaki K, Nakayama T, Oka S, Urano T, Kimura M, Kawana R, Yamamura AM. Am J Dis Child; 1990 Aug; 144(8):905-10. PubMed ID: 2198807 [Abstract] [Full Text] [Related]
3. [Clinico-immunologic evaluation of a trivalent vaccine against measles, rubella and mumps]. Schettini F, Manzionna MM, De Mattia D, Amendola F, Di Bitonto G. Minerva Pediatr; 1989 Mar; 41(3):117-22. PubMed ID: 2747598 [Abstract] [Full Text] [Related]
5. [Experience with preventive measles, mumps and rubella vaccination in unified Germany]. Gerike E, Tischer A. Gesundheitswesen; 1993 Jan; 55(1):38-9. PubMed ID: 8435543 [Abstract] [Full Text] [Related]
6. A field with a liver measles-mumps-rubella vaccine. Walters VW, Miller SA, Jackson JE, Kenny MT. Clin Pediatr (Phila); 1975 Oct; 14(10):928-33. PubMed ID: 1100294 [Abstract] [Full Text] [Related]
11. Interference between strains in live virus vaccines, I: Combined vaccination with measles, mumps and rubella vaccine. Berger R, Just M, Glück R. J Biol Stand; 1988 Oct; 16(4):269-73. PubMed ID: 3198657 [Abstract] [Full Text] [Related]
12. Clinical evaluation of a new measles-mumps-rubella combined live virus vaccine in the Dominican Republic. Ehrenkranz NJ, Ventura AK, Medler EM, Jackson JE, Kenny MT. Bull World Health Organ; 1975 Oct; 52(1):81-5. PubMed ID: 764997 [Abstract] [Full Text] [Related]
17. [Field trial with a new human diploid cell vaccine (HDCV) against measles, mumps and rubella]. Just M, Berger R, Glück R, Wegmann A. Schweiz Med Wochenschr; 1985 Nov 30; 115(48):1727-30. PubMed ID: 4081704 [Abstract] [Full Text] [Related]
18. Efficacy and safety of vaccination of marrow transplant recipients with a live attenuated measles, mumps, and rubella vaccine. Ljungman P, Fridell E, Lönnqvist B, Bolme P, Böttiger M, Gahrton G, Linde A, Ringdén O, Wahren B. J Infect Dis; 1989 Apr 30; 159(4):610-5. PubMed ID: 2647859 [Abstract] [Full Text] [Related]
19. Protection of mumps in children with various underlying diseases: application of a live attenuated mumps and trivalent measles-rubella-mumps (MRM) vaccines in these children. Kanesaki T, Baba K, Tsuda N, Yabuuchi H, Yamanishi K, Takahashi M. Biken J; 1986 Dec 30; 29(3-4):63-71. PubMed ID: 3304276 [Abstract] [Full Text] [Related]
20. The elimination of indigenous measles, mumps, and rubella from Finland by a 12-year, two-dose vaccination program. Peltola H, Heinonen OP, Valle M, Paunio M, Virtanen M, Karanko V, Cantell K. N Engl J Med; 1994 Nov 24; 331(21):1397-402. PubMed ID: 7969278 [Abstract] [Full Text] [Related] Page: [Next] [New Search]